Q.G.C.M. van Hoesel

1.1k total citations
19 papers, 914 citations indexed

About

Q.G.C.M. van Hoesel is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Q.G.C.M. van Hoesel has authored 19 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Q.G.C.M. van Hoesel's work include Sarcoma Diagnosis and Treatment (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Q.G.C.M. van Hoesel is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Q.G.C.M. van Hoesel collaborates with scholars based in Netherlands, United States and Slovakia. Q.G.C.M. van Hoesel's co-authors include P A Speth, C. Haanen, Peter A. Steerenberg, Anouk van Dijk, Daan J.A. Crommelin, G. Storm, Dick J. De Wildt, Sarah R. Klein, Jaap Verweij and Ian Judson and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Controlled Release and British Journal of Cancer.

In The Last Decade

Q.G.C.M. van Hoesel

19 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Q.G.C.M. van Hoesel Netherlands 14 440 258 215 210 189 19 914
T Ohnuma United States 16 812 1.8× 554 2.1× 48 0.2× 202 1.0× 354 1.9× 40 1.7k
G Brufman Israel 11 1.3k 3.1× 244 0.9× 118 0.5× 445 2.1× 145 0.8× 38 1.9k
Rut Isacson Israel 10 1.3k 2.9× 378 1.5× 130 0.6× 441 2.1× 296 1.6× 22 1.9k
Ger‐Jan Sanderink France 10 348 0.8× 189 0.7× 150 0.7× 90 0.4× 88 0.5× 12 712
Von Hoff United States 16 540 1.2× 295 1.1× 221 1.0× 171 0.8× 25 0.1× 39 1.1k
Xiuyun Tian China 18 400 0.9× 403 1.6× 72 0.3× 264 1.3× 68 0.4× 78 1.1k
Claudia Casarsa Italy 13 409 0.9× 584 2.3× 165 0.8× 58 0.3× 159 0.8× 17 1.3k
S. Gundersen Norway 17 470 1.1× 246 1.0× 63 0.3× 116 0.6× 31 0.2× 59 886
Dominique de Valeriola Belgium 13 521 1.2× 305 1.2× 40 0.2× 228 1.1× 55 0.3× 47 887
Donehower Rc United States 8 508 1.2× 196 0.8× 55 0.3× 90 0.4× 110 0.6× 10 805

Countries citing papers authored by Q.G.C.M. van Hoesel

Since Specialization
Citations

This map shows the geographic impact of Q.G.C.M. van Hoesel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q.G.C.M. van Hoesel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q.G.C.M. van Hoesel more than expected).

Fields of papers citing papers by Q.G.C.M. van Hoesel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Q.G.C.M. van Hoesel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q.G.C.M. van Hoesel. The network helps show where Q.G.C.M. van Hoesel may publish in the future.

Co-authorship network of co-authors of Q.G.C.M. van Hoesel

This figure shows the co-authorship network connecting the top 25 collaborators of Q.G.C.M. van Hoesel. A scholar is included among the top collaborators of Q.G.C.M. van Hoesel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Q.G.C.M. van Hoesel. Q.G.C.M. van Hoesel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Buijs, Ciska, Sjoerd Rodenhuis, Caroline Seynaeve, et al.. (2007). Prospective Study of Long-Term Impact of Adjuvant High-Dose and Conventional-Dose Chemotherapy on Health-Related Quality of Life. Journal of Clinical Oncology. 25(34). 5403–5409. 24 indexed citations
2.
Hannemann, Juliane, Petra Kristel, Harm van Tinteren, et al.. (2006). Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy. British Journal of Cancer. 95(10). 1334–1341. 54 indexed citations
3.
Rodenhuis, Sjoerd, M. Bontenbal, Q.G.C.M. van Hoesel, et al.. (2006). Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer. Annals of Oncology. 17(4). 588–596. 57 indexed citations
4.
Švancárová, L, Jean‐Yves Blay, Ian Judson, et al.. (2002). Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. European Journal of Cancer. 38(4). 556–559. 96 indexed citations
5.
Verweij, Jaap, W. Ruka, J. Buesa, et al.. (2000). Randomized Phase II Study of Docetaxel versus Doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.. International Journal of Clinical Oncology. 18. 2081–2086. 30 indexed citations
6.
Pas, Tommaso De & Q.G.C.M. van Hoesel. (1999). Comments on: Should patients with advanced soft tissue sarcomas be treated with chemotherapy.. European Journal of Cancer. 327. 1 indexed citations
7.
Veth, R.P.H., et al.. (1999). Osteosarcoma: Oncologic and functional results. A single institutional report covering 22 years. Journal of Surgical Oncology. 72(3). 124–129. 20 indexed citations
8.
Verhagen, C.A.H.H.V.M., Q.G.C.M. van Hoesel, C.P.T. Schijf, & P.H.M. de Mulder. (1996). The management of granulosa cell tumor of the ovary – a case history. Annals of Oncology. 7(5). 521–524. 2 indexed citations
9.
Hoesel, Q.G.C.M. van, et al.. (1995). The art of limb salvage in musculoskeletal oncology. Critical Reviews in Oncology/Hematology. 21(1-3). 77–103. 19 indexed citations
10.
Echteld, Cees J. A. van, J. H. Kirkels, T. J. C. Ruigrok, et al.. (1991). Chronic cardiotoxicity of adriamycin studied in a rat model by 31P NMR. NMR in Biomedicine. 4(1). 16–24. 8 indexed citations
11.
Crommelin, Daan J.A., W. Eling, Peter A. Steerenberg, et al.. (1991). Liposomes and immunoliposomes for controlled release or site specific delivery of anti-parasitic drugs and cytostatics. Journal of Controlled Release. 16(1-2). 147–154. 14 indexed citations
12.
Hoesel, Q.G.C.M. van. (1990). Interleukin-2 therapy for human cancer. Lung. 168(S1). 1069–1074. 3 indexed citations
13.
Wagener, D. J. Th., Q.G.C.M. van Hoesel, Sing Hiem Yap, et al.. (1989). Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 25(2). 131–134. 16 indexed citations
14.
15.
Speth, P A, Q.G.C.M. van Hoesel, & C. Haanen. (1988). Clinical Pharmacokinetics of Doxorubicin. Clinical Pharmacokinetics. 15(1). 15–31. 351 indexed citations
16.
Steerenberg, Peter A., G. Storm, Gerard de Groot, et al.. (1988). Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). Cancer Chemotherapy and Pharmacology. 21(4). 299–307. 35 indexed citations
17.
Hoesel, Q.G.C.M. van, Peter A. Steerenberg, Daan J.A. Crommelin, et al.. (1984). Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.. PubMed. 44(9). 3698–705. 104 indexed citations
18.
Oort, W. J. van, et al.. (1983). Analysis of adriamycin and adriamycinol in micro volumes of rat plasma. Journal of Chromatography B Biomedical Sciences and Applications. 272(2). 421–427. 35 indexed citations
19.
Hoesel, Q.G.C.M. van & Herbert M. Pinedo. (1980). Complete remission of mediastinal germ-cell tumors with cis-dichlorodiammineplatinum(II) combination chemotherapy.. PubMed. 64(2-3). 319–21. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Ohnuma Breakdown of academic impact, for papers by G Brufman Breakdown of academic impact, for papers by Rut Isacson Breakdown of academic impact, for papers by Ger‐Jan Sanderink Breakdown of academic impact, for papers by Von Hoff Breakdown of academic impact, for papers by Xiuyun Tian Breakdown of academic impact, for papers by Claudia Casarsa Breakdown of academic impact, for papers by S. Gundersen Breakdown of academic impact, for papers by Dominique de Valeriola Breakdown of academic impact, for papers by Donehower Rc
Rankless by CCL
2026